Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience

BACKGROUND AND OBJECTIVE: Here, we present real-world data on the incidence and risk factors of acute exacerbation (AE) in patients with chronic fibrotic interstitial pneumonia (CFIP) treated with antifibrotic agents, which has been previously poorly documented. METHODS: We retrospectively examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Kodai, Ichikado, Kazuya, Ichiyasu, Hidenori, Anan, Keisuke, Yasuda, Yuko, Suga, Moritaka, Sakagami, Takuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593518/
https://www.ncbi.nlm.nih.gov/pubmed/31238929
http://dx.doi.org/10.1186/s12890-019-0880-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593518/
https://www.ncbi.nlm.nih.gov/pubmed/31238929
http://dx.doi.org/10.1186/s12890-019-0880-0

Ejemplares similares